Genitourinary Malignancies: Current Perspectives in Bladder, Kidney, and Testis Cancer
The Abramson Cancer Center of the University of Pennsylvania
Last Modified: August 18, 2005
Conference Dates: Friday, November 4, 2005
Conference Location: The Rittenhouse Hotel, 210 West Rittenhouse Square, Philadelphia, PA
Sponsoring Group: Abramson Cancer Center of the University of Pennsylvania
Conference Objectives: At the completion of this conference, participants should be able to:
- Identify risk factors in bladder cancer and how those factors influence treatment options;
- Discuss treatment options for patients with advanced bladder disease;
- Describe the role of surgical intervention for patients with kidney cancer;
- Identify new approaches and data in the treatment of kidney cancer;
- Evaluate the role of genetics in patients with testis cancer;
- Describe new approaches in the treatment of testis cancer
Who Should Attend: Urologic surgeons, medical oncologists, radiation oncologists, pathologists, hematology oncology fellows, urologic oncology nurses, and other health care professionals involved in the treatment of patients with genitourinary cancer.
- 8:30-8:40 Welcome and Introduction. S. Bruce Malkowicz, MD
- 8:40-9:10 Tumor Markers in the Diagnosis and Surveillance of Bladder Cancer. S. Bruce Malkowicz, MD
- 9:10-9:50 Pathologic Dilemmas in Bladder Cancer. Priti Lal, MD
- 9:50-10:20 Contemporary Issues in the Treatment of Superficial Bladder Cancer. Michael O'Donnell, MD, FACS
- 10:30-11:10 Contemporary Management of Muscle Invasive Bladder Cancer. S. Bruce Malkowicz, MD
- 11:10-11:50 The Role of Systemic Chemotherapy in Invasive Bladder Cancer. David J. Vaughn, MD
- 1:15-1:45 The Spectrum of Kidney Cancer. John E. Tomaszewski, MD
- 1:45-2:25 Surgical Management of Renal Cell Carcinoma. Steven C. Campbell, MD, PhD
- 2:25-3:05 Minimally Invasive Approaches to Small Renal Masses. Timothy W.I. Clark, MD
- 3:05-3:25 Advances in the Treatment of Metastatic Renal Cell Carcinoma. Keith T. Flaherty, MD
- 3:45-4:15 The Genetic Aspects of Testis Cancer. Katherine L. Nathanson, MD
- 4:15-4:55 Contemporary Clinical Care of Testis Cancer. David J. Vaughn, MD
Registration Information: To register or receive a conference brochure, please contact Mary Graham at email@example.com or by phone at 215-662-7328.
Conference Fees: $190.00 for Physicians; $95.00 for Nurses and other health care professionals, No fee for faculty, staff, fellows at students of University of Pennsylvania
Online Registration: All fields are required.
Make checks payable to: Trustees, University of Pennsylvania. Mail payment and registration to:
Abramson Cancer Center of the University of Pennsylvania
3400 Spruce St. - 16 Penn Tower
Philadelphia, PA 19104-4283
P: 215-662-7328 • F: 215-614-1854
Continuing Education: Yes. The University of Pennsylvania School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Continuing Education: Yes
Miscellany: The University of Pennsylvania School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Small Cell Carcinoma of Urinary Bladder Incidence Up
Nov 29, 2011 - The incidence of small cell carcinoma of the urinary bladder increased from 1991 to 2005, with elderly Caucasian men being the most commonly affected, according to a study published in the Dec. 1 issue of Cancer.
Frequently Asked Questions
National Cancer Institute
I Wish You Knew
How cancer patients have changed my life
Blogs and Web Chats
OncoLink Blogs give our readers a chance to react to and comment on key cancer news topics and provides a forum for OncoLink Experts and readers to share opinions and learn from each other.
Facing a new cancer diagnosis or changing the course of your current treatment? Let our cancer nurses help you through!